Put on hold music: Roche delays Spark buyout for the 9th — and quite possibly not the last — time

It’s beginning to take on the will-they-won’t-they character of a sitcom or a victorian novel. Nine months after Roche announced it was acquiring gene therapy pioneer Spark Therapeutics, the deal is still not done and today, the Swiss giant announced a 9th delay.